Navigation Links
Demonstrating the Value of Benchmarking in an Uncertain Economy
Date:6/5/2008

CHAPEL HILL, N.C., June 5 /PRNewswire/ -- Benchmarking is not a luxury; it is an activity that is useful in all economic climates. This research excerpt presents a survey analysis of 30 companies and in-depth interviews with seven of these companies on how companies are using benchmarking in a difficult economy.

The complete study addresses areas such as: hot topics companies are choosing to benchmark, the goals of benchmarking studies, how companies are demonstrating value through these studies, the criteria they use to show relevance and value and companies' lessons learned. This excerpt focuses on how companies demonstrate the value of their benchmarking organization.

Best Practices, LLC's report is a guidebook for benchmarking teams seeking to create value for their organizations and communicate that value out of other teams. Best Practices, LLC has organized the report around the key findings of alignment, clarity, and speed.

Download a complimentary excerpt "Demonstrating the Value of Benchmarking in an Uncertain Economy," at http://www3.best-in-class.com/dr311.htm . To access additional operations studies, browse the Best Practice Database at http://www3.best-in-class.com/Database

An annual membership to Best Practices Database is an ideal way for the "do-it-yourself" executive to get quick, ready-to-implement best practices gleaned from best-in-class companies. To sign up for Best Practices Database tour click at this link: http://www3.best-in-class.com/dw212.htm .

For more information and to learn more about this research and Best Practices Database service available to executives. Contact Cameron Tew at (919) 767-9246 or ctew@best-in-class.com

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts wor
'/>"/>

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. EpiCept Releases New Data Demonstrating Prolonged Five-Year Leukemia-Free Survival for AML Patients Treated with Ceplene(TM) + IL-2
2. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
3. iGuard.org Presents New Data on Statins at FDA Workshop Demonstrating How Patient-Reported Information Can Enhance Drug Safety Knowledge
4. ZIP codes and property values predict obesity rates
5. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
6. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
7. Cincinnati Adoption Agency Invited to Participate in Values Voter Presidential Debate
8. Study Questions Flu Shots Value for Older People
9. Glycemic index values are variable, report researchers
10. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
11. Boston Scientific Announces New Initiatives to Increase Shareholder Value
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Volunteers from the Church of Scientology of Denmark ... with massive distribution of Truth About Drugs ... on Strøget, the famous Copenhagen walking street. Popular ... its ambiance, some quarter of a million people stroll ... , These activities are part of a coordinating effort ...
(Date:7/30/2014)... fuel cancer as well as evolutionary changes in a ... occur randomly throughout the genome. , However, recent studies ... of multiple mutations that arise simultaneously and in close ... are frequently found in regions where chromosomal rearrangements take ... Cell Reports , may one day lead to new ...
(Date:7/30/2014)... MA (PRWEB) July 30, 2014 ... of authentication, access management and secure communications solutions ... Imprivata OneSign ® is the most widely selected ... McKesson Paragon or Horizon electronic medical records (EMR) ... increase of about 11 percent in the last ...
(Date:7/30/2014)... Hamilton Facial Plastic Surgery is happy ... on July 30th. After months of planning, Dr. Hamilton ... state-of-the-art suite, located only steps away from the original ... one-on-one patient comfort, shorter wait times, and generally a ... new office-suite will continue to provide the same wide ...
(Date:7/30/2014)... (July 30, 2014) The phrase "we caught it early" ... in the midst of a cancer diagnosis. Combating cancer ... to a certain part of the body, gives patients ... breast, skin, colon, prostate and other forms of cancer ... health care providers recommend cancer screenings as a precautionary ...
Breaking Medicine News(10 mins):Health News:Biologists describe mechanism promoting multiple DNA mutations 2Health News:Imprivata Achieves 51 Percent Single Sign-on Market Share Amongst U.S. Hospitals Using McKesson Paragon or Horizon EMR Systems, According to HIMSS Analytics 2Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3
... OAKLAND, Calif., Aug. 11 The American Heart ... Oakland and,Stanford University Medical Center $3.89 million over ... heart research center that aims to define,optimal clinical ... chronic,heart failure., The Kaiser Permanente Division of ...
... Aug. 11 Perrigo Company,(Nasdaq: PRGO ; ... chewable tablets (famotidine 10 mg; calcium carbonate 800mg;,magnesium ... under their store,brand labels. Perrigo won a successful ... to Pepcid Complete(R) marketed by,Johnson & Johnson - ...
... Inc., a,global leading manufacturer of orthodontic products and ... a full-service,orthodontic laboratory. The O2 Orthodontic Laboratory is ... Carlsbad, CA., "The O2 Orthodontic Laboratory is ... it allows the Company to further its,commitment to ...
... (GICD) and UCSF have identified a key regulatory factor ... the extensive network of arteries, veins, and capillaries that ... research, published in the latest issue of Developmental ... for a wide variety of diseases, such as heart ...
... examinations of PSA screening in younger men, a study published ... of men under age 50 reported undergoing a prostate specific ... year, yet only one in three young black men reported ... , Overall, that,s pretty good news for white men at ...
... chemical might lead to drug treatments for humans , , SUNDAY, ... of mice resistant to diet-induced obesity. , The findings ... in people. They also shed light on the brain circuitry ... energy (i.e., food) an animal takes in and how quickly ...
Cached Medicine News:Health News:Kaiser Permanente - Stanford Heart Research Center Funded to Study Treatment Outcomes 2Health News:Kaiser Permanente - Stanford Heart Research Center Funded to Study Treatment Outcomes 3Health News:Kaiser Permanente - Stanford Heart Research Center Funded to Study Treatment Outcomes 4Health News:Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide 2Health News:Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide 3Health News:Ortho Organizers(R) Opens a Full-Service Orthodontic Laboratory 2Health News:Gladstone scientists identify single microRNA that controls blood vessel development 2Health News:Gladstone scientists identify single microRNA that controls blood vessel development 3Health News:Study finds more PSA screening awareness needed among high-risk groups 2Health News:Scientists Create Mice Resistant to Obesity 2Health News:Scientists Create Mice Resistant to Obesity 3
(Date:7/30/2014)... 2014 Cynosure, Inc. (NASDAQ: ... for non-invasive and minimally invasive applications, today announced that the ... Officer and Chief Financial Officer Timothy W. Baker ... 53, will continue to serve as CFO and will take ... remains Chairman and Chief Executive Officer. "Tim ...
(Date:7/30/2014)... CLARA, Calif. , July 30, 2014 ... economy, released a study today that examines ... biopharma and medical device companies.  According to the annual ... saw the biggest potential returns since SVB started tracking ... year of the IPO.  Built on solid healthcare M&A ...
(Date:7/30/2014)... WOODCLIFF LAKE, N.J. and SAN DIEGO ... Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today that ... Phase 3 trials of lorcaserin entitled, "Early Weight Loss While ... 52 Weight-Loss Outcomes," was recently published in the online issue ... The Obesity Society. The objective of these analyses was to ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7
... , SALT LAKE CITY, Dec. 16 ... "Company"), a medical device company engaged in the development and ... that Joe Pepper, PhD, has been appointed to the TechniScan ... "Joe has extensive experience running small to large medical devices ...
... EVANSTON, Ill., Dec. 16 Naurex Inc., a new clinical ... disorders based on its novel GFPA NMDA receptor modulators, today ... of its lead compound GLYX-13 and has successfully dosed the ... functional partial agonist (GFPA) selective modulator of the NMDA receptor, ...
Cached Medicine Technology:In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 2In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 3Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3
... K-ASSAY ASO / RF / ... to be used as a ... concentration for monitoring the performance ... Rheumatoid Factor (RF), and C-Reactive ...
... of benchtop microcentrifuges with the 5424. ... aerosol-tight rotor and a unique, contoured ... ,Model 5424 expands its application range ... microcentrifuge tubes, miniprep spin columns and ...
... hand, the Jarvik 2000 pump is about the ... titanium shell sits a direct-current motor, a rotor ... moving part: a small, spinning titanium impeller that ... 7 liters per minute. Rather than take over ...
... VentrAssist is a new third generation cardiac assist ... heart transplants for patients suffering heart failure., ,It ... left ventricle of the diseased heart to help ... restoring a better quality of life. , ,It ...
Medicine Products: